Crofelemer

A proprietary gastro-intestinal compound in clinical development for four distinct product indications

investor relations

Board of Directors

Lisa Conte

Chief Executive Officer, Founder

Ms. Conte is responsible for strategy development, partnerships, recruitment, fund-raising, and investor and public relations at Napo and has been its Chief Executive Officer since its founding. Prior to founding Napo, she founded Shaman Pharmaceuticals, Inc., a natural product pharmaceutical company, in 1989. As CEO of several companies, she has raised over US$220 million (including leading an IPO). From 1987 to 1989 Ms. Conte was a Vice President at Technology Funding, Inc., a venture capital firm where she was responsible for the analysis and management of health care industry investments. From 1985 to 1987 she conducted risk and strategy audits for start-up healthcare companies at Strategic Decisions Group, a management consulting firm. While studying for her MBA, Ms. Conte interned at Eli Lilly & Company, where she worked with their internal venture capital group to identify promising new biotechnology companies. Ms. Conte received her AB in Biochemistry from Dartmouth College, her MS in Physiology/Pharmacology from the University of California at San Diego and her MBA from the Amos Tuck School, Dartmouth College. She is the recipient of several entrepreneurship awards, including the 1994 E&Y Entrepreneur of the Year Award, and has sat on several industry boards.

Lisa Conte